Provided by Tiger Trade Technology Pte. Ltd.

Sarepta Therapeutics

21.17
-0.5600-2.58%
Post-market: 21.200.0300+0.14%19:57 EDT
Volume:2.57M
Turnover:54.39M
Market Cap:2.22B
PE:-2.97
High:22.02
Open:21.75
Low:20.76
Close:21.73
52wk High:64.80
52wk Low:10.42
Shares:104.79M
Float Shares:95.17M
Volume Ratio:1.26
T/O Rate:2.70%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-7.1300
EPS(LYR):-7.1300
ROE:-53.47%
ROA:-11.24%
PB:1.94
PE(LYR):-2.97

Loading ...

Will Roche’s New Global Elevidys Phase 3 Trial Shift Sarepta Therapeutics' (SRPT) Gene Therapy Narrative?

Simply Wall St.
·
2 hours ago

Sarepta Therapeutics Price Target Maintained With a $5.00/Share by HC Wainwright & Co.

Dow Jones
·
14 hours ago

Analysts Conflicted on These Healthcare Names: Rhythm Pharmaceuticals (RYTM) and Sarepta Therapeutics (SRPT)

TIPRANKS
·
15 hours ago

Roche decision could hurt Sarepta in U.S., says H.C. Wainwright

TIPRANKS
·
15 hours ago

A Look At Sarepta Therapeutics (SRPT) Valuation After Recent Share Price Swings

Simply Wall St.
·
Apr 10

RBC Adjusts Price Target on Sarepta Therapeutics to $19 From $18, Maintains Sector Perform Rating

MT Newswires Live
·
Apr 07

Is Sarepta Therapeutics (SRPT) Starting To Look Interesting Again After Recent Share Price Rebound

Simply Wall St.
·
Apr 07

Wells Fargo Remains a Buy on Sarepta Therapeutics (SRPT)

TIPRANKS
·
Apr 01

Sarepta Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)

THOMSON REUTERS
·
Apr 01

Sarepta Therapeutics Is Maintained at Sell by Citigroup

Dow Jones
·
Mar 26

Deutsche ups Sarepta target, says 35% stock rally overdone

TIPRANKS
·
Mar 26

Sarepta price target raised to $35 from $29 at Wedbush

TIPRANKS
·
Mar 26

Wedbush Raises Price Target on Sarepta Therapeutics to $35 From $29, Keeps Outperform Rating

MT Newswires Live
·
Mar 26

Sarepta Therapeutics, Inc. : Deutsche Bank Raises Target Price to $14 From $12

THOMSON REUTERS
·
Mar 26

Analysts Offer Insights on Healthcare Companies: Neurogene (NGNE), Vertex Pharmaceuticals (VRTX) and Sarepta Therapeutics (SRPT)

TIPRANKS
·
Mar 26

Sarepta Therapeutics Inc : Wedbush Raises Target Price to $35 From $29

THOMSON REUTERS
·
Mar 26

Bernstein Reaffirms Their Hold Rating on Sarepta Therapeutics (SRPT)

TIPRANKS
·
Mar 26

Sarepta Therapeutics: Early TRiM Platform Promise Outweighed by High Clinical Risk and Valuation Downside, Justifying Sell Rating

TIPRANKS
·
Mar 26

Sarepta price target raised to $13 from $9 at Citi

TIPRANKS
·
Mar 26

U.S. RESEARCH ROUNDUP- Equitable Holdings, Robinhood Markets, Wingstop

Reuters
·
Mar 26